Medicare GLP-1 Bridge 2026: The CFO Financial Planning Guide for Payer and Provider Leaders

CMS just announced that starting July 1, Medicare beneficiaries with Part D coverage can access GLP-1 medications for $50 per month through December 2027. The drug cost for health plans: zero. The operational and strategic exposure on both the payer and provider sides is not.

This is a demonstration program, not a permanent benefit. That distinction is exactly what makes the financial planning window so narrow.